Nov. 14 at 3:11 PM
As long as we’re not forced to sell, the short-term drops in the market only test our psychology; what truly matters is whether the companies we invest in have the strength to grow their business over time. The data came in positive, and the fact that the company will soon resume its clinical studies is the clearest sign of that. Remember, the market sometimes tests our patience, but value always returns to where it belongs eventually—so we shouldn’t rush into decisions at the wrong price or at the wrong time. I don’t stress myself with buy–sell trades, because patience is the strongest tool in this journey. Personally, I believe the stock could reach around 4 dollars in the next 2–3 months, and I only set a daily stop below 1 dollar to manage risk; beyond that, I don’t overthink it and focus instead on what the process teaches us.
$TNYA